GP2411 (biosimilar denosumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GP2411 (biosimilar denosumab), covering 2023-03-08 to 2023-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis [Phase 3]